Larvol Delta - Vasomune-and-AnGes-Announce-Drug-Candidate-AV001-Receives-Positive-Recommendation-from-the-IDSMB-for-AV001004-Phase-2a-Study

AV-001 - Vasomune Therap, AnGes MG

https://www.businesswire.com/news/home/20231114795277/en/Vasomune-and-AnGes-Announce-Drug-Candidate-AV-001-Receives-Positive-Recommendation-from-the-IDSMB-for-AV001-004-Phase-2a-Study

Nov 14, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next